Abstract | BACKGROUND: METHODS: A cross-sectional study done in FCHL subjects and gender and age-matched healthy subjects. A clinical assessment, lipid profile and plasma concentrations of insulin, apolipoprotein CIII (apo CIII), apolipoprotein AII ( apo AII), high sensitive C-reactive protein ( HS-CRP), adiponectin and leptin were documented in 147 FCHL patients and 147 age-matched healthy subjects. Multivariate regression models were performed to investigate the independent determinants of VLDL-TG and apo B levels adjusting for confounding factors. RESULTS: The variables that determined the VLDL-triglyceride content as a surrogate of VLDL composition were apo CIII (β=0.365, p<0.001), insulin (β=0.281, p<0.001), Apo AII (β=0.145, p<0.035), and adiponectin levels (β=-0.255, p<0.001). This model explained 34% of VLDL composition (VLDL-TG) variability. However, none of these variables were independent contributors of apo B-containing particles. CONCLUSIONS: In patients with FCHL apo CIII, apo AII and adiponectin are major novel factors determining the VLDL particle composition. However, such factors do not explain apo B-containing particles.
|
Authors | Ivette Cruz-Bautista, Roopa Mehta, Javier Cabiedes, Cristina García-Ulloa, Luz Elizabeth Guillen-Pineda, Paloma Almeda-Valdés, Daniel Cuevas-Ramos, Carlos A Aguilar-Salinas |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 438
Pg. 160-5
(Jan 01 2015)
ISSN: 1873-3492 [Electronic] Netherlands |
PMID | 25172037
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier B.V. All rights reserved. |
Chemical References |
- Apolipoprotein C-III
- Apolipoproteins B
- Biomarkers
- Lipoproteins, VLDL
- Triglycerides
- very low density lipoprotein triglyceride
|
Topics |
- Adult
- Aged
- Apolipoprotein C-III
(blood)
- Apolipoproteins B
(blood)
- Biomarkers
(blood)
- Case-Control Studies
- Cohort Studies
- Cross-Sectional Studies
- Female
- Follow-Up Studies
- Humans
- Hyperlipidemia, Familial Combined
(blood, diagnosis)
- Lipoproteins, VLDL
(blood)
- Male
- Middle Aged
- Prognosis
- Triglycerides
(blood)
|